共 52 条
Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms
被引:58
作者:
Liu, Gong-Ping
[1
]
Zhang, Yao
[1
]
Yao, Xiu-Qing
[1
]
Zhang, Chang-E
[1
]
Fang, Jiang
[1
]
Wang, Qun
[1
]
Wang, Jian-Zhi
[1
]
机构:
[1] Huazhong Univ Sci & Technol, Tongii Med Coll, Key Lab Neurol Dis Hubei Prov, Dept Pathophysiol, Wuhan 430030, Peoples R China
基金:
中国国家自然科学基金;
关键词:
glycogen synthase kinase-3 beta;
protein phosphatase 2A;
I-2(PP-2A);
D O I:
10.1016/j.neurobiolaging.2007.03.012
中图分类号:
R592 [老年病学];
C [社会科学总论];
学科分类号:
03 ;
0303 ;
100203 ;
摘要:
The activity of protein phosphatase-2A (PP-2A) is significantly suppressed in the brain of Alzheimer's disease (AD) patients, but the mechanism is not understood. Here, we found an in vivo association of glycogen synthase kinase 30 (GSK-3 beta) with inhibitor-2 of PP-2A (I-2(PP-2A)). The activation of GSK-3 resulted in accumulation of I-2(PP-IA) with concomitant suppression of PP-2A activity and increases of tau phosphorylation in HEK293, N2a and PC12 cells, while inhibition of GSK-3 caused decreases of I-2(PP-2A) with increased PP-2A activity and decreased tau phosphorylation. A positive correlation between GSK-3 beta and I-2(PP-2A) (R = 0.9158) and a negative correlation between GSK3 beta and PP-2A (R = -0.9166) were detected. GSK-3 activation did not affect I-2(PP-2A) mRNA level, while it increased the mRNA level of a heterogeneous ribonucleoprotein A18 (hnRNP A18). The activation of GSK-3 increased the expression and the activity of proteasome system. It suggests that activation of GSK-3 inhibits PP-2A through up-regulation of I-2(PP-2A) with hnRNP A18-involved mechanism. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1348 / 1358
页数:11
相关论文